Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 17.16
    Last
  • 0.01  -0.06%
    Today's Change
  • 17.17
    Previous Close
  • Today
     
    9.51
    23.30
    52 Week Low - High
8:10 pm ET 4/29/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding49 million
Market Cap$848 million
Return on Equity ttm14.74%
Last DividendSUPN:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.303
EPS: Year Est. 12/16 ttm0.620
 
EPS: Quarterly Actual 12/15 0.14
EPS: Quarterly Est. 3/16 0.09
 
Price/Earnings ttm56.56
Relative Price/Earnings2.956
Earnings Growth Rate-36.17
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$144 million
Net Income$14 million
Total Assets$189 million
Employees344
Web Sitewww.supernus.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!